Skip to main content
. 2020 Aug 2;22(5):e13338. doi: 10.1111/tid.13338

TABLE 1.

Summary of reported COVID‐19 infection cases among kidney transplant recipients

Patient Age

Co‐morbid

Conditions

Clinical Presentation

SARS Co‐V‐2

Diagnosis

Imaging Treatment Immunosuppressive Agent Modifications Outcome
1 50

HIV

HTN

Asthma, Steatohepatitis

Resolved HBV

Fevers

Chills

Nasal congestion

Cough

Anosmia

Dysgeusia

NP swab None None MMF reduced Recovered
2 4 28 Lupus‐like syndrome

Low grade fevers

Malaise

Sore throat

Rhinorrhea

NP swab CT chest: normal Oseltamivir None Recovered
3 7 75

COPD

HTN

Heart disease

Fevers

Dyspnea

Myalgias

NP swab

CT chest:

extensive bilateral GGO

Hydroxychloroquine

Lopinavir/ritonavir

Tacrolimus discontinued

MMF discontinued

Expired
4 7 52 HTN

Fevers

Dyspnea

Diarrhea,

Myalgias

AKI

NP swab CT chest: extensive bilateral GGO

Hydroxychloroquine

Darunavir/cobicistat

Colchicine

Tacrolimus discontinued

MMF discontinued

Remained hospitalized
5‐40 15 32‐77 Not available

Fever (58%)

Cough (53%)

Dyspnea (44%)

Myalgias (36%)

Diarrhea (22%)

Not available Imaging consistent with viral pneumonia (96%) b

Hydroxychloroquine (86%)

Azithromycin (46%) Leronlimab (7%) Tocilizumab (7%) High‐dose glucocorticoids (7%)

Anti‐metabolite discontinued (86%)

Tacrolimus discontinued (21%)

Mechanic al ventilation (39%)

Remained hospitalized (43%)

Expired (28%)

41 8 50

HTN

DM

Fever

Cough

NP swab CXR: minimal interstitial lesions None None Recovered
42 10 50

Splenectomy

ITP

PTLD

HTN

Fever

Vomiting

NP swab CXR diffuse bilateral infiltrates Lopinavir/ritonavir Hydroxychloroquine Interferon Beta

Tacrolimus discontinued

Everolimus discontinued

Remained in ICU
43 11 52 Not available

Fatigue

Cough

Dyspnea

Chest pain and tightness

Anorexia

Nausea

Abdominal pain

OP swab Chest CT: GGO and consolidation

Methylprednisolone

IVIG

Interferon α

Tacrolimus discontinued

MMF discontinued

Recovered

Repeat OP swab negative on day 18

44 12 38 Not available

Fever

Cough

OP swab Chest CT: typical signs of viral infection Oseltamivir or arbidol a

Tacrolimus reduced

MMF discontinued

Recovered

Repeat OP swab negative on day 26

45 12 64 Bladder cancer

Fever

Productive cough Myalgias

Fatigue

OP swab Chest CT: typical signs of viral infection Oseltamivir or arbidol a

Glucocorticoid discontinued

MMF discontinued

Residual dyspnea at time of hospital discharge
46 12 37 HTN

Fever

Cough

OP swab

Chest CT:

typical signs of viral infection

Oseltamivir or arbidol a

IVIG

Tacrolimus discontinued MMF discontinued

Recovered

Repeat OP swab negative on day 22

47 12 47 Not available

Fever

Productive cough Myalgias

Fatigue

OP swab Chest CT with typical signs of viral infection Oseltamivir or arbidol a

Tacrolimus discontinued MMF discontinued

Glucocorticoid discontinued

Resolved

Repeat OP swab positive on day 18

48 12 38

HTN

DM

Fever

Productive cough Myalgias

Fatigue

OP swab Chest CT with typical signs of viral infection Oseltamivir or arbidol a None

Resolved

Repeat OP swab negative on day 18

49 13 49 Not available

Fever

Respiratory symptoms

NP swab Chest CT with multifocal GGO

Lopinavir/ritonavir Ribavirin

Interferon‐alpha‐2b Methylprednisolone

None Resolved
50 14 58 Testicular cancer

Fever

Dyspnea

Cough

NP swab Chest CT peripheral GGO None Belatacept discontinued MMF discontinued Resolved

Abbreviarions: AKI, acute kidney injury; COPD, chronic obstructive pulmonary disease; CXR, chest radiograph; DM, diabetes mellitus; GGO, ground‐glass opacity; HBV, hepatitis B virus; HTN, hypertension; ITP, idiopathic thrombocytopenic purpura; IVIG, intravenous immunoglobulin; MMF, mycophenolate mofetil; NP, nasopharyngeal; OP, oropharyngeal; PTLD, post‐transplant lymphoproliferative disorder.

a

Not specified which of the two medications (oseltamivir or arbidol) the patient received.

b

Imaging modality not specified.